MicroPort CardioFlow Medtech (HKSE:02160) Cash-to-Debt : 15.11 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. MicroPort CardioFlow Medtech's cash to debt ratio for the quarter that ended in Dec. 2023 was 15.11.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, MicroPort CardioFlow Medtech could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for MicroPort CardioFlow Medtech's Cash-to-Debt or its related term are showing as below:

HKSE:02160' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.54 Med: 16.36 Max: 38.7
Current: 15.11

During the past 6 years, MicroPort CardioFlow Medtech's highest Cash to Debt Ratio was 38.70. The lowest was 0.54. And the median was 16.36.

HKSE:02160's Cash-to-Debt is ranked better than
76.19% of 840 companies
in the Medical Devices & Instruments industry
Industry Median: 1.97 vs HKSE:02160: 15.11

MicroPort CardioFlow Medtech Cash-to-Debt Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

MicroPort CardioFlow Medtech Cash-to-Debt Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

2.70

38.70

17.60

19.55

15.11

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial					17.60	17.15	19.55	12.71	15.11

Competitive Comparison of MicroPort CardioFlow Medtech's Cash-to-Debt

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort CardioFlow Medtech's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Cash-to-Debt falls into.

MicroPort CardioFlow Medtech Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

MicroPort CardioFlow Medtech's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1164.967	/	(31.247	+	45.842)
	=	15.11

MicroPort CardioFlow Medtech's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1164.967	/	(31.247	+	45.842)
	=	15.11

MicroPort CardioFlow Medtech (HKSE:02160) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

MicroPort CardioFlow Medtech Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines